PO
Predictive Oncology Inc.
POAI · NASDAQ
$5.95 N/A (+$5.95)
Piotroski F-Score Weak
3/9Valuation
-
N/A EV/FFO N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
46 /100
Moderate Beta 1.35x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na POAI
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Raymond F. Vennare
Employees
23
Headquarters
Pittsburgh